Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 558 Carcinoma, Non-Small-Cell Lung 514 Prostatic Neoplasms 336 Colorectal Neoplasms 273 Neoplasms 269 Multiple Myeloma 267 Leukemia, Myeloid, Acute 225 Squamous Cell Carcinoma of Head and Neck 217 Lung Neoplasms 210 Neoplasm Metastasis 205 Carcinoma, Hepatocellular 198 Melanoma 175 Triple Negative Breast Neoplasms 174 Pancreatic Neoplasms 171 Recurrence 153 Ovarian Neoplasms 152 Lymphoma 142 Glioblastoma 136 Brain Neoplasms 134 Sarcoma 131 Carcinoma, Renal Cell 128 Lymphoma, Large B-Cell, Diffuse 126 Leukemia, Lymphocytic, Chronic, B-Cell 126 Head and Neck Neoplasms 124 Stomach Neoplasms 123 Precursor Cell Lymphoblastic Leukemia-Lymphoma 110 Rectal Neoplasms 109 Myelodysplastic Syndromes 104 Uterine Cervical Neoplasms 100 Urinary Bladder Neoplasms 100

Interventions

Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Resectable Esophageal Cancer × 1 year × Clear all

NCT07385664 2026-02-04

FAIR

Zhejiang Cancer Hospital

Phase 2 Not yet recruiting

Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡